US$45 Million Private Placement to Major Shareholders
Filed with ASX · · 2 pages · English
Earlier from Mesoblast
- Reinstatement to Quotation
- Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
- Third Quarter Results Presentation
- MSB Q3 Financial Results and Operational Highlights
- S&P DJI Announces March 2022 Quarterly Rebalance
Later from Mesoblast
- Preliminary Final Report
- MSB Annual Financial Results and Operational Highlights
- Submits New Information to FDA IND File for SR-aGVHD
- First Quarter Financial Results on Form 6-K
- MSB Q1 Financial Results and Operational Highlights
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast